---
layout: post
title: "Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products; Draft Guidance for Industry; Availability; Extension of Comment Period"
date: 2026-02-05 19:08:16 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2020-01322
original_published: 2020-01-27 00:00:00 +0000
significance: 8.00
---

# Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products; Draft Guidance for Industry; Availability; Extension of Comment Period

**Published:** February 05, 2026 19:08 UTC
**Source:** Federal Register
**Original Published:** January 27, 2020 00:00 UTC
**Document Number:** 2020-01322

## Summary

The Food and Drug Administration (FDA or the Agency) is extending the comment period for the notice entitled "Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products; Draft Guidance for Industry; Availability" that appeared in the Federal Register of December 20, 2019. The Agency is taking this action in response to requests for an extension to allow interested persons additional time to submit comments.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2020/01/27/2020-01322/demonstrating-substantial-evidence-of-effectiveness-for-human-drug-and-biological-products-draft)
- API: https://www.federalregister.gov/api/v1/documents/2020-01322

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
